Alx Oncology Holdings (ALXO) Other Non-Current Assets (2019 - 2026)

Alx Oncology Holdings (ALXO) has 8 years of Other Non-Current Assets data on file, last reported at $2.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 54.94% year-over-year to $2.9 million; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (down 54.94% YoY), and the FY2025 full-year result was $149000.0, down 97.87% from the prior year.
• Other Non-Current Assets improved to $2.9 million in Q1 2026, from $149000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $16.3 million in Q3 2022 to a low of $66000.0 in Q2 2022.
• A 5-year average of $8.2 million and a median of $9.0 million in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets sank 99.25% in 2022 and surged 9827.78% in 2024, its largest moves.
• Tracing ALXO's Other Non-Current Assets over 5 years: stood at $14.9 million in 2022, then declined by 0.25% to $14.9 million in 2023, then sank by 53.04% to $7.0 million in 2024, then sank by 97.87% to $149000.0 in 2025, then surged by 1867.11% to $2.9 million in 2026.
• Business Quant data shows ALXO's Other Non-Current Assets at $2.9 million in Q1 2026, $149000.0 in Q4 2025, and $9.0 million in Q3 2025.